The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Consolidation nivolumab plus ipilimumab or nivolumab alone following concurrent chemoradiation for patients with unresectable stage III non-small cell lung cancer: BTCRC LUN 16-081.
 
Greg Andrew Durm
Honoraria - AstraZeneca; Curio Science
Research Funding - AstraZeneca (Inst); Bristol-Myers Squibb (Inst); Merck (Inst)
 
Hirva Mamdani
Consulting or Advisory Role - MorphoSys (I); Seagen (I); Zentalis
 
Sandra K. Althouse
No Relationships to Disclose
 
Salma K. Jabbour
Consulting or Advisory Role - IMX Medical Reviewer; Merck Sharp & Dohme; Syntactx
Research Funding - Merck Sharp & Dohme (Inst); NCI (Inst)
 
Apar Kishor Ganti
Consulting or Advisory Role - AstraZeneca; Beigene; Blueprint Medicines; Cardinal Health; Cardinal Health; Flagship Biosciences; G1 Therapeutics; Genentech/Roche; Genzyme; Jazz Pharmaceuticals; Mirati Therapeutics
Research Funding - Apexigen (Inst); Merck (Inst); Nektar (Inst); Novartis (Inst); Novartis (Inst); Takeda; TopAlliance BioSciences Inc (Inst)
 
Shadia Ibrahim Jalal
Consulting or Advisory Role - Adaptimmune
Research Funding - Astex Pharmaceuticals; AstraZeneca/MedImmune; Tesaro
 
Jason Alan Chesney
Research Funding - Amgen; Bristol-Myers Squibb; Iovance Biotherapeutics; Replimune
Patents, Royalties, Other Intellectual Property - University of Louisville US Patents
 
Jarushka Naidoo
Honoraria - AstraZeneca/MedImmune; Bristol-Myers Squibb; Daiichi Sankyo/Lilly; Merck; Pfizer; Roche/Genentech; Takeda
Consulting or Advisory Role - AstraZeneca/MedImmune; Bristol-Myers Squibb; Daiichi Sankyo/Lilly; Kaleido Biosciences; Merck; Merck KGaA; Pfizer; Roche/Genentech; Takeda
Research Funding - Amgen (Inst); AstraZeneca (Inst); Merck (Inst); Novartis (Inst); Roche/Genentech (Inst)
Travel, Accommodations, Expenses - AstraZeneca/MedImmune; Bristol-Myers Squibb
 
Borys Hrinczenko
Honoraria - Bayer; Curio Science
Consulting or Advisory Role - Bayer; Curio Science
Research Funding - Alexion Pharmaceuticals (Inst); Amgen (Inst); AstraZeneca (Inst); EMD Serono (Inst); Incyte (Inst); Lilly (Inst); Lilly (Inst); Merrimack (Inst); Tragara (Inst)
Patents, Royalties, Other Intellectual Property - Swain, GM, Peteu, SF, Hrinczenko, BW (2020). "Electrode and sensor apparatus and related methods for detection of nitric oxide and peroxynitrate". (U.S. Patent No. 10,859,527). U.S. Patent and Trademark Office. http://rb.gy/mo1lve. (Inst)
 
Mary Jo J. Fidler
Honoraria - AstraZeneca; Genentech; Jazz Pharmaceuticals; Merck
Consulting or Advisory Role - Abbvie (I); AstraZeneca; Daiichi Sankyo/Astra Zeneca; G1 Therapeutics; Genentech (I); Gilead Sciences; Lynx Group; Plexus; Rakuten Medical (Inst); Silverback Therapeutics
Speakers' Bureau - Genentech; Merck
Research Funding - alkermes (Inst); AstraZeneca (Inst); Biodesix; CytomX Therapeutics (Inst); Jounce Therapeutics (Inst); Merck (Inst); Novartis (Inst); Pfizer/EMD Serono; Rakuten Medical (Inst)
 
Ticiana Leal
Consulting or Advisory Role - AstraZeneca; AstraZeneca; AstraZeneca; Bayer; Bayer; Blueprint Medicines; Boehringer Ingelheim; Daiichi Sankyo/Astra Zeneca; Daiichi Sankyo/Lilly; Daiichi-Sankyo; Eisai; EMD Serono; EMD Serono; Genentech; Janssen; Jazz Pharmaceuticals; Lilly; Merck; Merck; Mirati Therapeutics; Novocure; Takeda
 
Lawrence Eric Feldman
Research Funding - BrightPath Biotheraputics; E.R. Squibb Sons, LLC (Inst); Genentech (Inst); Merck (Inst); Roche (Inst); Soligenix (Inst)
 
Naomi Fujioka
Consulting or Advisory Role - AstraZeneca (Inst); Takeda
Research Funding - Astellas Pharma (Inst); Bristol-Myers Squibb (Inst); MedImmune (Inst); Merck Sharp & Dohme (Inst)
 
Nasser H. Hanna
Honoraria - UpToDate
Research Funding - AstraZeneca/MedImmune (Inst); Bristol-Myers Squibb (Inst); Genentech (Inst); Merck KGaA (Inst)